Opportunity

The Akston Opportunity

Sage Tap Poder is proud to partner with Akston Biosciences, a cutting-edge biotechnology company at the forefront of innovation. Akston specializes in the development of transformative therapies, leveraging advanced protein engineering to create impactful solutions across multiple therapeutic areas.

If you’re interested in exploring opportunities with Sage Tap Poder (STPCM), a venture capital firm dedicated to investing in transformative technologies, here are several ways to get involved and learn more:

đź’Ľ Explore Current Investment Opportunities

STPCM actively partners with innovative companies that meet their four key investment criteria:

  1. Significant Market: Ventures addressing real problems in growing markets.
  2. De-risked Technology: Technologies that have been extensively tested and validated.
  3. Proven Management: Teams with a track record of building agile and focused organizations.
  4. Clear Exit Strategy: Investments positioned for an exit or acquisition within approximately 24 months.

🤝 Connect with STPCM

Whether you’re an entrepreneur seeking investment or an investor interested in partnering, STPCM welcomes inquiries. You can reach out through their contact page or email them directly at

 

If you’re interested in exploring active investment opportunities with STPCM, here are two ventures currently open for participation:

 

Koning Health – Advancing Breast Cancer Detection

Koning Health is revolutionizing breast imaging with its Vera™ Breast CT system, offering:

True 3D Imaging: Provides detailed images, detecting smaller cancers often missed by traditional mammograms.

No Compression: Enhances patient comfort by eliminating the need for breast compression during scans.

Rapid Scans: Delivers 3D breast imaging in as little as 7 seconds.

With FDA, CE, and China approvals, and a global market potential exceeding $40 billion, Koning Health is seeking to raise $5 million to scale its operations globally.

Learn more: Koning Health

 

MissMedical Ventures – Innovating Fetal Monitoring

MissMedical Ventures has developed a patented fetal scalp sensor array that measures fetal oxygen saturation (SpOâ‚‚) in real-time, addressing critical issues in labor and delivery:

Enhanced Accuracy: Reduces false positives in fetal distress detection, potentially decreasing unnecessary emergency C-sections.

Improved Outcomes: Provides vital oxygen data, aiding in timely and accurate clinical decisions during labor.

This innovation targets a significant gap in obstetric care, aiming to improve maternal and fetal health outcomes.

Learn more: Miss Medical Ventures

 

Both opportunities align with STPCM’s focus on investing in ventures that address substantial market needs with de-risked technologies and clear exit strategies. If you have further questions or need assistance connecting with these ventures, feel free to ask!

Learn More About STPCM’s Approach

STPCM employs a process-driven approach to investing, emphasizing:stpcm.com

  • Tailored Investment Strategies: Customizing strategies for Special Purpose Vehicle (SPV) structures to align with the needs of entrepreneurs and investors.
  • Strong Investor Relationships: Building long-term partnerships with family offices, institutional partners, and accredited investors.
  • Focus on Exceptional Ventures: Collaborating with ventures that demonstrate sustainable competitive advantages and adhere to high ethical standards.stpcm.com

Their focus areas include early-stage ventures with innovative strategies, scalable growth solutions, and SPV investments.

Why Akston?

Pioneering Science

Akston’s proprietary technology platform enables the creation of highly stable, long-acting protein therapeutics, addressing critical unmet needs in healthcare.

Innovative Pipeline

With a robust pipeline targeting immunology, infectious diseases, and oncology, Akston is positioned to deliver groundbreaking treatments to market.

Strategic Vision

Akston is led by a team of experienced scientists and industry veterans, driving the company toward scalable growth and long-term success.

Investment Highlights

Differentiated Technology

Akston’s platform provides unique advantages in therapeutic stability, manufacturability, and efficacy.

Market Opportunity

Addressing multibillion-dollar markets with high growth potential, Akston offers significant value creation opportunities for stakeholders.

Proven Leadership

A team with a proven track record of innovation, execution, and strategic partnerships in the biotech sector.